153 related articles for article (PubMed ID: 11895970)
21. Disruption of Parasite hmgb2 Gene Attenuates Plasmodium berghei ANKA Pathogenicity.
Briquet S; Lawson-Hogban N; Boisson B; Soares MP; Péronet R; Smith L; Ménard R; Huerre M; Mécheri S; Vaquero C
Infect Immun; 2015 Jul; 83(7):2771-84. PubMed ID: 25916985
[TBL] [Abstract][Full Text] [Related]
22. Gene expression analysis reveals early changes in several molecular pathways in cerebral malaria-susceptible mice versus cerebral malaria-resistant mice.
Delahaye NF; Coltel N; Puthier D; Barbier M; Benech P; Joly F; Iraqi FA; Grau GE; Nguyen C; Rihet P
BMC Genomics; 2007 Dec; 8():452. PubMed ID: 18062806
[TBL] [Abstract][Full Text] [Related]
23. Establishment of a murine model of cerebral malaria in KunMing mice infected with Plasmodium berghei ANKA.
Ding Y; Xu W; Zhou T; Liu T; Zheng H; Fu Y
Parasitology; 2016 Oct; 143(12):1672-80. PubMed ID: 27574013
[TBL] [Abstract][Full Text] [Related]
24. Evidence for multiple pathologic and protective mechanisms of murine cerebral malaria.
Jennings VM; Lal AA; Hunter RL
Infect Immun; 1998 Dec; 66(12):5972-9. PubMed ID: 9826380
[TBL] [Abstract][Full Text] [Related]
25. Profiles of cytokine production in relation with susceptibility to cerebral malaria.
de Kossodo S; Grau GE
J Immunol; 1993 Nov; 151(9):4811-20. PubMed ID: 8409439
[TBL] [Abstract][Full Text] [Related]
26. Lambda-carrageenan treatment exacerbates the severity of cerebral malaria caused by Plasmodium berghei ANKA in BALB/c mice.
Recuenco FC; Takano R; Chiba S; Sugi T; Takemae H; Murakoshi F; Ishiwa A; Inomata A; Horimoto T; Kobayashi Y; Horiuchi N; Kato K
Malar J; 2014 Dec; 13():487. PubMed ID: 25495520
[TBL] [Abstract][Full Text] [Related]
27. Role of IL-10-producing regulatory B cells in control of cerebral malaria in Plasmodium berghei infected mice.
Liu Y; Chen Y; Li Z; Han Y; Sun Y; Wang Q; Liu B; Su Z
Eur J Immunol; 2013 Nov; 43(11):2907-18. PubMed ID: 23893352
[TBL] [Abstract][Full Text] [Related]
28. Toll-like receptor modulation of murine cerebral malaria is dependent on the genetic background of the host.
Griffith JW; O'Connor C; Bernard K; Town T; Goldstein DR; Bucala R
J Infect Dis; 2007 Nov; 196(10):1553-64. PubMed ID: 18008236
[TBL] [Abstract][Full Text] [Related]
29. Estradiol, but not dehydroepiandrosterone, decreases parasitemia and increases the incidence of cerebral malaria and the mortality in plasmodium berghei ANKA-infected CBA mice.
Libonati RM; Cunha MG; Souza JM; Santos MV; Oliveira SG; Daniel-Ribeiro CT; Carvalho LJ; do Nascimento JL
Neuroimmunomodulation; 2006; 13(1):28-35. PubMed ID: 16699290
[TBL] [Abstract][Full Text] [Related]
30. Participation of lymphocyte subpopulations in the pathogenesis of experimental murine cerebral malaria.
Yañez DM; Manning DD; Cooley AJ; Weidanz WP; van der Heyde HC
J Immunol; 1996 Aug; 157(4):1620-4. PubMed ID: 8759747
[TBL] [Abstract][Full Text] [Related]
31. T cell response in malaria pathogenesis: selective increase in T cells carrying the TCR V(beta)8 during experimental cerebral malaria.
Boubou MI; Collette A; Voegtlé D; Mazier D; Cazenave PA; Pied S
Int Immunol; 1999 Sep; 11(9):1553-62. PubMed ID: 10464176
[TBL] [Abstract][Full Text] [Related]
32. Plasmodium berghei: cerebral malaria in CBA mice is not clearly related to plasma TNF levels or intensity of histopathological changes.
Carvalho LJ; Lenzi HL; Pelajo-Machado M; Oliveira DN; Daniel-Ribeiro CT; Ferreira-da-Cruz MF
Exp Parasitol; 2000 May; 95(1):1-7. PubMed ID: 10864512
[TBL] [Abstract][Full Text] [Related]
33. Cerebral malaria protection in mice by species-specific Plasmodium coinfection is associated with reduced CC chemokine levels in the brain.
Clark CJ; Phillips RS
Parasite Immunol; 2011 Nov; 33(11):637-41. PubMed ID: 21851365
[TBL] [Abstract][Full Text] [Related]
34. The lack of suppressor of cytokine signalling-1 (SOCS1) protects mice from the development of cerebral malaria caused by Plasmodium berghei ANKA.
Bullen DV; Hansen DS; Siomos MA; Schofield L; Alexander WS; Handman E
Parasite Immunol; 2003 Mar; 25(3):113-8. PubMed ID: 12911518
[TBL] [Abstract][Full Text] [Related]
35. Minocycline prevents cerebral malaria, confers neuroprotection and increases survivability of mice during Plasmodium berghei ANKA infection.
Apoorv TS; Babu PP
Cytokine; 2017 Feb; 90():113-123. PubMed ID: 27865203
[TBL] [Abstract][Full Text] [Related]
36. A Virus Hosted in Malaria-Infected Blood Protects against T Cell-Mediated Inflammatory Diseases by Impairing DC Function in a Type I IFN-Dependent Manner.
Hassan A; Wlodarczyk MF; Benamar M; Bassot E; Salvioni A; Kassem S; Berry A; Saoudi A; Blanchard N
mBio; 2020 Apr; 11(2):. PubMed ID: 32265335
[TBL] [Abstract][Full Text] [Related]
37. VEGF and LPS synergistically silence inflammatory response to Plasmodium berghei infection and protect against cerebral malaria.
Canavese M; Dottorini T; Crisanti A
Pathog Glob Health; 2015 Sep; 109(6):255-65. PubMed ID: 26392042
[TBL] [Abstract][Full Text] [Related]
38. Depletion of CD4+ or CD8+ T-cells prevents Plasmodium berghei induced cerebral malaria in end-stage disease.
Hermsen C; van de Wiel T; Mommers E; Sauerwein R; Eling W
Parasitology; 1997 Jan; 114 ( Pt 1)():7-12. PubMed ID: 9011069
[TBL] [Abstract][Full Text] [Related]
39. Identification of the Plasmodium berghei resistance locus 9 linked to survival on chromosome 9.
Bopp SE; Rodrigo E; González-Páez GE; Frazer M; Barnes SW; Valim C; Watson J; Walker JR; Schmedt C; Winzeler EA
Malar J; 2013 Sep; 12():316. PubMed ID: 24025732
[TBL] [Abstract][Full Text] [Related]
40. Co-infection with Trypanosoma cruzi protects mice against early death by neurological or pulmonary disorders induced by Plasmodium berghei ANKA.
Egima CM; Macedo SF; Sasso GR; Covarrubias C; Cortez M; Maeda FY; Costa FT; Yoshida N
Malar J; 2007 Jul; 6():90. PubMed ID: 17620126
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
